Laser Versus Cryotherapy for the Treatment of Recalcitrant Warts
NCT ID: NCT05616078
Last Updated: 2022-11-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
110 participants
INTERVENTIONAL
2022-11-30
2025-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Laser Versus Cryotherapy in the Treatment of Warts
NCT01808443
Salicylic Acid Versus Cryotherapy for the Treatment of HPV1-induced Plantar Warts
NCT05617950
Carbon Dioxide Laser and Cryotherapy in Treatment of Warts
NCT03166137
Combination Therapy of Imiquimod 5%Cream and Cryotherapy vs Monotherapy for Common Warts:Randomized Comparative Trial.
NCT06973473
Comparison of Cryotherapy and Peeling Agent in the Treatment of Common Warts
NCT05712811
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
laser treatment
LP-Nd:YAG laser treatment
laser treatment
a maximum of 4 sessions, with an interval of 3 to 4 weeks
cryotherapy
cryotherapy with liquid nitrogen
cryotherapy
a maximum of 4 sessions, with an interval of 3 to 4 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
laser treatment
a maximum of 4 sessions, with an interval of 3 to 4 weeks
cryotherapy
a maximum of 4 sessions, with an interval of 3 to 4 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Total number of warts is ≤10 .
* Aged 18 years or older.
Exclusion Criteria
* Patients have taken immunosuppressant drugs (such as oral corticosteroids) during the past three months.
* Patients have impaired healing eg due to diabetes, vitamin A deficiency, hyperthyroidism and hypothyroidism.
* Patients have autoimmune diseases (such as systemic lupus erythematosus, dermatomyositis, scleroderma or other diseases).
* Patients are pregnant or ready for pregnancies or breast-feeding.
* Patients have cold intolerance (such as cold urticaria, cryoglobulinaemia, cold agglutinin syndrome or Raynaud's syndrome).
* Patients have local pain intolerance.
* Patients have local hypoesthesia.
* Patients are unable to tolerate laser or cryotherapy.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The 306 Hospital of People's Liberation Army
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shichao Lu, MD
Role: PRINCIPAL_INVESTIGATOR
The 306 Hospital of People's Liberation Army
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
306PLA-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.